Bladder Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have not had a diagnostic bladder tumour removal procedure (TURBT) but whose biopsy or camera examination of the bladder suggests high-grade cancer, cancer in the lining of the bladder (CIS), multiple tumours, or a tumour larger than 3 cm — with specific scan scores and no signs of enlarged lymph nodes on MRI.
- People who have had a diagnostic bladder tumour removal procedure (TURBT) and whose tissue results confirm high-risk bladder cancer that has not spread into the muscle wall, including specific categories of tumour stage, grade, or recurrence — and no signs of enlarged lymph nodes on MRI.
- People whom the trial doctor has assessed as likely to benefit from surgical removal of the bladder (radical cystectomy).
- People whose blood counts, kidney function, liver function, and blood clotting results fall within the ranges required by the trial (confirm specific values with the trial site).
- People whose heart and lung function is considered suitable for major abdominal surgery, as assessed by the trial doctor.
- People with no previous history of cancer, lymph node removal surgery, or immune system-related disease.
- People aged between 18 and 75 years.
- People who have not received any pre-surgery (neoadjuvant) treatment before joining.
- People with a good general level of physical functioning, rated 0 or 1 on a standard medical scale (meaning fully active or able to carry out light activity).
- People who are willing to take part voluntarily, can provide written consent, and are able to follow the trial schedule and requirements.
Who may not be able to join:
- People whose bladder cancer has been confirmed by tissue testing or imaging to have reached a more advanced stage, or whose MRI shows enlarged lymph nodes in the pelvis.
- People whom the trial doctor has assessed as unable to safely undergo surgical removal of the bladder.
- People who have previously received chemotherapy or immunotherapy given throughout the body (systemic treatment).
- People who have an active autoimmune disease requiring ongoing treatment, or another condition that requires long-term use of high-dose hormones or other immune-suppressing medicines.
- People who have had major surgery or a serious physical injury within the 28 days before enrolling.
- People who have received a live vaccine within the 28 days before enrolling.
- People who have had a serious or ongoing infection requiring antibiotic, antifungal, or antiviral medicines within the 14 days before enrolling.
- People who have taken any Chinese herbal medicine or traditional Chinese medicine products intended to treat cancer within the 14 days before enrolling.
- People who are currently participating in another clinical trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Qiang Lu, PhD, The First Affiliated Hospital with Nanjing Medical University
Phone: +86 13951813528
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
PFS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.